Patients with urine [TIMP-2]x[IGFBP7] ≥ 0.3 (ng/ml)2/1000 and AKI had a higher risk of receiving RRT and had the highest ICU and 60-day mortality (50%) (Table S5). This evidence concerns the gene IGFBP7 and acute kidney injury.